Clinical Trials · NCT03572387

A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment

CompletedPhase 2Gonadorelin (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Icahn School of Medicine at Mount Sinai
Enrollment
14
Start date
Aug 2018
Locations
1 site, United States
Primary endpoint
Number of Participants With PSA Response
View Gonadorelin compound reference